Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioniche Life Sciences Inc.
Bioniche Reports Fiscal 2009 Third Quarter
May 20th, 2009
Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, announced financial results for the third quarter of its 2009 fiscal year, ending March 31, 2009. "The year-to-date revenue growth of 23% percent in our Bioniche Animal Health business unit is very impressive in our current economic climate," said Graeme McRae, Chairman, President & CEO of Bioniche Life Sciences Inc. "This base business has supported the Company's research and development efforts for 30 years, and continues to do so." The Company is currently pursuing several financing alternatives including issuing additional debt,...
Source: Vaccine Weekly (2009-05-20)
|
